By Nelson Chao, MD
2009-09-01
Dr. Chao indicated no relevant conflicts of interest.
Naveiras O, Nardi V, Wenzel PL, et al. Bone-marrow
adipocytes as negative regulators of the haematopoietic microenvironment.
Nature. 2009;460:259-63.
In our current epidemic of obesity,
fat is a dreaded word. By some estimates, Americans spend $40 billion per year
on weight-loss programs and diets. Now comes yet more evidence that fat is bad …
for hematopoiesis. We have learned a lot about hematopoietic niches. Signals
imparted from these cells directly contribute to the fate of the stem cells, whether
by direct signaling or gradients of secreted factors and extracellular matrix.
The importance of niches for hematopoiesis has been established through
alterations of osteoblasts or vascular beds. The conventional wisdom was that
as the patient ages or is treated with radiation or chemotherapy, the marrow pulp
is gradually replaced by more and more fat (more correctly, by adipocytes),
thought to simply “fill in the space.”
The
current work by Naveiras et al., from George Daley’s lab, upends this conventional
wisdom. They began their studies by comparing the contents of hematopoietic
stem cells and their progenitors in different vertebral bodies. In the mouse,
the central vertebral bodies (thorax) contain the fewest adipocytes, and as one
moves toward the tail, starting at the third or fourth tail segments, it
becomes full of adipocytes. The percentage of all hematopoietic progenitor classes
was reduced 2- to 3-fold in the adipocyte-rich tail vertebrae compared with the
thoracic vertebral bodies. They then tested the effects of radiation and
hematopoietic transplantation on a genetically modified mouse, the lipoatrophic
“fatless” A-ZIP/F1 mouse, which is unable to form adipocytes. When these
fatless mice were compared with normal controls, the fatless mice rescued
hematopoiesis in the tail and had higher hemoglobin and white blood cells in
the circulation. All the known hematopoietic progenitors were increased in the
fatless mouse. Interestingly, however, when comparing short-term versus long-term
hematopoietic stem cells in normal animals, the tail vertebral body’s cells
resulted in more multilineage, long-term engraftment, suggesting that the residual
cells in the tail marrow were more quiescent.
Lastly,
they tested whether blocking adipogenesis could have an impact on
hematopoiesis. They utilized a compound called biphenol A diglycidyl ether
(BADGE) that blocks peroxisome proliferator-activated receptor gamma (PPAR-γ),
which was shown to prevent adipocyte formation in the marrow. Animals treated
with BADGE after hematopoietic cell transplantation had higher peripheral blood
counts and more colony formingunits.
Taken together, these data suggest that, as in
most areas of biology, there are positive and negative regulators of most
cellular functions. In hematopoiesis, the osteoblasts (and likely other cells)
supply a positive signal, whereas the adipocytes appear to be a negative
regulator, perhaps keeping the cells in a more quiescent stage. Moreover, the
possibility of regulation of adipocytes through inhibiting PPAR-γ or other
pathways raises the potential of enhancing engraftment after hematopoietic cell
transplantation.
back to top